Is Component-Specific Antibody Testing Sufficient to Replace the Oral Food Challenge in the Diagnostics of Peanut-Sensitized Children? A Proof-of-Concept Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137415 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Klementyna Łyżwa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Pulmonology and Allergology, Medical University of Warsaw, Zwirki i Wigury 63A, 05-092 Warsaw, Poland. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Arachis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
(1) Peanut allergy is associated with high risk of anaphylaxis which could be prevented by oral immunotherapy. Patients eligible for immunotherapy are selected on the basis of a food challenge, although currently the assessment of antibodies against main peanut molecules (Ara h 1, 2, 3 and 6) is thought to be another option. (2) The current study assessed the relationship between the mentioned antibodies, challenge outcomes, skin tests and some other parameters in peanut-sensitized children. It involved 74 children, divided into two groups, based on their response to a food challenge. (3) Both groups differed in results of skin tests, levels of component-specific antibodies and peanut exposure history. The antibody levels were then used to calculate thresholds for prediction of challenge results or symptom severity. While the antibody-based challenge prediction revealed statistical significance, it failed in cases of severe symptoms. Furthermore, no significant correlation was observed between antibody levels, symptom-eliciting doses and the risk of severe anaphylaxis. Although in some patients it could result from interference with IgG4, the latter would not be a universal explanation of this phenomenon. (4) Despite some limitations, antibody-based screening may be an alternative to the food challenge, although its clinical relevance still requires further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Pulmonology and Allergology, Medical University of Warsaw, Zwirki i Wigury 63A, 05-092 Warsaw, Poland.
- Startmed Medical Center, Partyzantow 23, 05-092 Lomianki, Poland.
- Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw, Banacha 2, 02-097 Warsaw, Poland.
- Biostructure Research Center, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland.
ORCID-Profile: Klementyna Łyżwa, Katarzyna Grzela
Zitieren
APA
Łyżwa, K., Prasek, K., Krupa-Łaska, A., Zielińska, J., Krejner-Bienias, A., Chojnowska-Wójtowicz, M., Zagórska, W., Kulus, M., Grzela, A., Grzela, T., & Grzela, K. (2024). Is Component-Specific Antibody Testing Sufficient to Replace the Oral Food Challenge in the Diagnostics of Peanut-Sensitized Children? A Proof-of-Concept Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137415
Vancouver
Łyżwa K, Prasek K, Krupa-Łaska A, Zielińska J, Krejner-Bienias A, Chojnowska-Wójtowicz M, et al. Is Component-Specific Antibody Testing Sufficient to Replace the Oral Food Challenge in the Diagnostics of Peanut-Sensitized Children? A Proof-of-Concept Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137415
BibTeX
@article{ywa2024,
author = {Łyżwa, Klementyna and Prasek, Klaudia and Krupa-Łaska, Anna and Zielińska, Joanna and Krejner-Bienias, Alicja and Chojnowska-Wójtowicz, Magdalena and Zagórska, Wioletta and Kulus, Marek and Grzela, Adam and Grzela, Tomasz and Grzela, Katarzyna},
title = {Is Component-Specific Antibody Testing Sufficient to Replace the Oral Food Challenge in the Diagnostics of Peanut-Sensitized Children? A Proof-of-Concept Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137415}
}
EUVIMED